Tuberculosis (TB) is a serious public health problem worldwide. The combination of various
anti-TB drugs is mainly used to treat TB in clinical practice. Despite the availability of …

The use of particles to develop vaccines and treatments for a wide variety of diseases has
increased, and their success has been demonstrated in preclinical investigations. Accurately …

Mice deficient for granulocyte-macrophage colony-stimulating factor (GM-CSF−/−) are highly
susceptible to infection with Mycobacterium tuberculosis, and clinical data have shown that …

Background Tuberculosis is the leading cause of death by an infectious microorganism
worldwide. Conventional treatment lasts at least six months and has adverse effects; …

Although tuberculosis (TB) is an infectious disease, the progression of the disease following
Mycobacterium tuberculosis (MTB) infection is closely associated with the host's immune …

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb) infection, remains a global
health threat despite recent advances and insights into host-pathogen interactions and the …

Background: To investigate the expression levels of miRNA-29a (miR-29a), tumor necrosis
factor-α (TNF-α) and vascular endothelial growth factor (VEGF) in peripheral blood of …

Although classically associated with myelopoiesis, granulocyte-macrophage colony-
stimulating factor (GM-CSF) is increasingly recognized as being important for tuberculosis …

Mycobacterium tuberculosis (Mtb) latent infection can lead to reactivation. The design of new
strategies to prevent it is an important subject. B6D2F1 mice were infected intratracheally …

As components of the innate immune response, antimicrobial peptides (AMPs) efficiently
contribute to infection control and maintenance of a latent state in pulmonary tuberculosis …